Clinical use of Macklin-like radiological sign (Macklin effect): A systematic review.
Alessandro Belletti, Ottavia Pallanch, Matteo Aldo Bonizzoni...
https://pubmed.ncbi.nlm.nih.gov/36863617/Actively Recruiting
Led by Università Vita-Salute San Raffaele · Updated on 2025-08-12
110
Participants Needed
4
Research Sites
13 weeks
Total Duration
Researchers are investigating lung frailty and barotrauma in patients with Acute Respiratory Distress Syndrome ARDS, including those with COVID-19 and non-COVID-19 causes. Barotrauma is a common and serious complication in ARDS that can occur even in patients breathing spontaneously. The study aims to confirm the predictive value of a radiological sign called the Macklin effect, assess inflammatory markers, and develop a management algorithm for patients with this vulnerable lung condition. The study involves reviewing chest CT scans and analyzing blood and bronchoalveolar lavage fluid from ARDS patients to measure multiple inflammatory biomarkers. These include various interleukins, interferon, angiopoietin, tumor necrosis factor receptors, and proteins linked to lung injury and inflammation. The research includes a retrospective analysis of imaging and a prospective collection of samples and clinical data to identify lung frailty features and support personalized care strategies. Participants will undergo standard chest CT scans during their hospital stay and provide blood and bronchoalveolar lavage samples within 12 hours after intubation. Researchers will monitor barotrauma development over 30 days or until hospital discharge using imaging and clinical records. The study will analyze patient outcomes and biomarker profiles to better understand lung injury risks, aiming to improve early risk detection and tailor treatments for ARDS patients.
CONDITIONS
Laboratory Biomarkers and Pulmonary Interstitial Emphysema in ARDS (PIE-ARDS)
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Università Vita-Salute San Raffaele
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Within 12 hours after intubation
Participants undergo blood and bronchoalveolar lavage fluid collection and chest CT scans to analyze biomarkers and lung imaging for assessing lung frailty in ARDS.
1 to 2 visits depending on clinical status
Duration - Up to 30 days or until hospital discharge
Participants are observed to track the development of barotrauma and clinical outcomes related to ARDS during hospital stay.
Ongoing clinical assessments during hospital stay
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Alessandro Belletti, Ottavia Pallanch, Matteo Aldo Bonizzoni...
https://pubmed.ncbi.nlm.nih.gov/36863617/Alessandro Belletti, Jacopo D'Andria Ursoleo, Enrica Piazza...
https://pubmed.ncbi.nlm.nih.gov/39305092/Diego Palumbo, Alberto Zangrillo, Alessandro Belletti...
https://pubmed.ncbi.nlm.nih.gov/34392131/Sadayuki Murayama, Shinji Gibo
https://pubmed.ncbi.nlm.nih.gov/25431639/Valerie Maccarrone, Connie Liou, Belinda D'souza...
https://pubmed.ncbi.nlm.nih.gov/36889115/Fabio Guarracino, Rubia Baldassarri, Giulia Brizzi...
https://pubmed.ncbi.nlm.nih.gov/39843275/Gianluca Paternoster, Pietro Bertini, Alessandro Belletti...
https://pubmed.ncbi.nlm.nih.gov/35537972/Università Vita-Salute San Raffaele
Lead Sponsor